Apollo Cancer Centres launches Shield™ Multi-Cancer Detection, a blood-based test that can detect signs of multiple cancers ...

Merck (NYSE:MRK) reported positive Phase 3 results for tulisokibart, an anti-TL1A monoclonal antibody in moderate-to-severe ...

Nearly four in 10 women were initially told they had a UTI before later being diagnosed with bladder cancer. The post Bladder ...

Zydus and Apollo Hospitals collaborate to enhance access to a multi-cancer blood test for early detection in India.

Unlike conventional screening methods that typically target a single cancer, Shield MCD is designed to detect signals ...

India launches a single blood test screening for 10 cancers, improving early detection while complementing - not replacing - ...

GRAIL is the only company that has applied for MCED FDA premarket approval so far; if approved by the FDA and covered by ...

Zydus Lifesciences Ltd. has entered into an exclusive agreement with precision oncology company Guardant Health to introduce ...

Apollo Cancer Centres has partnered with Zydus Lifesciences to introduce Guardant Health's Shield Multi-Cancer Detection ...

Now cancer-free, Deion Sanders reflected on the difficult days that followed his bladder cancer diagnosis last year. Sanders, ...

Zydus Lifesciences gained 3.06% to Rs 1,133.30 after the company signed memorandum of understanding (MoU) with Apollo Hospitals to introduce Shield, Multi-Cancer Detection (MCD) test available in ...

Zydus Lifesciences and Apollo Hospitals partner to expand access to Shield Multi-Cancer Detection blood test in India, ...